Although attention-deficit/hyperactivity disorder (ADHD) is prevalent among adolescents in outpatient behavioral care, one of the few evidence-based treatment options, stimulant medication, is significantly underutilized. The Medication Integration Protocol (MIP) is a family-based intervention designed to help behavior therapists assume a lead role in educating clients about ADHD in adolescents, promoting family-centered decisions about medication initiation, and integrating medication management activities within behavioral treatment planning. This pilot study evaluated treatment fidelity and medication utilization for inner-city teens receiving MIP (n = 14) compared with a matched Historical Control (HC) group (n = 21) in a community clinic. Observational analyses revealed that in comparison with HC, MIP demonstrated basic protocol fidelity with regard to adherence to the MIP protocol, therapeutic alliance with the adolescent, and clinical focus on ADHD in session. MIP showed greater psychiatric evaluation completion and ADHD medication initiation than HC. Next steps in the ongoing development of MIP are outlined.
American Academy of Pediatrics. (2011). ADHD: Clinical practice guidelines for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128, 1007–1021. doi:10.1542/peds.2011-2654
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4.
BarkleyR. A. (2006). Associated cognitive, developmental, and health problems. In BarkleyR. A. (Ed.), Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed., pp. 122–183). New York, NY: Guilford.
5.
BuksteinO. G.CorneliusJ. (2006). Psychopharmacology of adolescents with substance use disorders: Using diagnostic-specific treatments. In LiddleH. A.RoweC. L. (Eds.), Adolescent substance abuse: Research and clinical advances (pp. 241–263). New York, NY: Cambridge University Press.
6.
BussingR.ZimaB. T.MasonD. M.PorterP. C.GarvanC. W. (2011). Receiving treatment for attention-deficit hyperactivity disorder: Do the perspectives of adolescents matter?Journal of Adolescent Health, 49, 7–14. doi:0.1016/j.jadohealth.2010.08.014
7.
CicchettiD. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6, 284–290. doi:10.1037/1040-3590.6.4.284
8.
CookT.CampbellD. (1979). Quasi-experimentation: Design and analysis issues for field settings. Boston, MA: Houghton Mifflin.
9.
CummingsC. M.FristadM. A. (2007). Medications prescribed for children with mood disorders: Effects of a family-based psychoeducation program. Experimental and Clinical Psychopharmacology, 15, 555–562. doi:10.1037/1064-1297.15.6.555
10.
DavisC. C.ClaudiusM.PalinkasL. A.WongJ. B.LeslieL. K. (2012). Putting families in the center: Family perspectives on decision making and ADHD and implications for ADHD care. Journal of Attention Disorders, 8, 675–684. doi:10.1177/1087054711413077
11.
EvansS. W.OwensJ. S.BunfordN. (2014). Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology, 43, 527–551. doi:10.1080/15374416.2013.850700
12.
FawL.HogueA.JohnsonS.DiamondG. M.LiddleH. A. (2005). The Adolescent Therapeutic Alliance Scale: Initial psychometrics and prediction of outcome in family-based substance abuse prevention counseling. Psychotherapy Research, 15, 141–154.
13.
FristadM. A. (2006). Psychoeducational treatment for school-aged children with bipolar disorder. Development and Psychopathology, 18, 1289–1306. doi:10.10170S0954579406060627
14.
HinshawS. P.SchefflerR. M. (2014). The ADHD explosion: Myths, medication, money, and today’s push for performance. New York, NY: Oxford University Press.
15.
HogueA.BobekM. (2013). Medication Integration Protocol (MIP): Provider manual. New York City, NY: The National Center on Addiction and Substance Abuse, Columbia University.
16.
HogueA.BobekM.TauG. Z.LevinF. R. (2014). Clinical strategies for integrating medication interventions into behavioral treatment for adolescent ADHD: The Medication Integration Protocol. Child & Family Behavior Therapy, 36, 280–304. doi:10.1080/07317107.2014.967631
17.
HogueA.DauberS.ChinchillaP.FriedA.HendersonC. E.InclanJ.. . . LiddleH. A. (2008). Assessing fidelity in individual and family therapy for adolescent substance abuse. Journal of Substance Abuse Treatment, 35, 137–147.
18.
HogueA.DauberS.HendersonC. E.BobekM.JohnsonC.LichvarE.MorgensternJ. (2014). Randomized trial of family therapy versus non-family treatment for adolescent behavior problems in usual care. Journal of Clinical Child & Adolescent Psychology. Advance online publication. doi:10.1080/15374416.2014.963857
19.
HogueA.DauberS.LichvarE.BobekM.HendersonC. E. (2015). Validity of therapist self-report ratings of fidelity to evidence-based practices for adolescent behavior problems: Correspondence between therapists and observers. Administration and Policy in Mental Health and Mental Health Services Research, 42, 229–243. doi:10.1007/s10488-014-0548-2
20.
HogueA.LiddleH. A.RoweC.TurnerR. M.DakofG. A.LaPannK. (1998). Treatment adherence and differentiation in individual versus family therapy for adolescent substance abuse. Journal of Counseling Psychology, 45, 104–114. doi:10.1037/0022-0167.45.1.104
21.
Institute of Medicine. (2006). Improving the quality of health care for mental and substance use conditions. Washington, DC: National Academies Press.
22.
JohnstonC.HommersenP.SeippC. (2008). Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: Relations to child and parent characteristics. Behavior Therapy, 39, 22–32. doi:10.1016/j.beth.2007.04.002
23.
JonesD. E.FosterE. M.Conduct Problems Prevention Research Group. (2009). Service use patterns for adolescents with ADHD and comorbid conduct disorder. The Journal of Behavioral Health Services & Research, 36, 436–449. doi:10.1007/s11414-008-9133-3
24.
KollinsS. H. (2007). Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). The American Journal on Addictions, 16, 35–44. doi:10.1080/10550490601082775
25.
KrainA. L.KendallP. C.PowerT. J. (2005). The role of treatment acceptability in the initiation of treatment for ADHD. Journal of Attention Disorders, 9, 425–434. doi:10.1177/1087054705279996
26.
LecrubierY.SheehanD. V.WeillerE.AmorimP.BonoraI.SheehanK. H.. . . DunbarG. C. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry, 12, 224–231. doi:10.1016/S0924-9338(97)83296-8
27.
LiddleH. A. (1995). Conceptual and clinical dimensions of a multidimensional, multisystems engagement strategy in family-based adolescent treatment. Psychotherapy: Theory, Research, Practice, Training, 32, 39–58. doi:10.1037/0033-3204.32.1.39
28.
LincolnT. M.WilhelmK.NestoriucY. (2007). Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis. Schizophrenia Research, 96, 232–245. doi:10.1016/j.schres.2007.07.022
29.
LopezM.TopracM.CrimsonM.BoemerB.BaumgartnerJ. (2005). A psychoeducational program for children with ADHD or depression and their families: Results from the CMAP feasibility study. Community Mental Health Journal, 41, 51–66. doi:10.1007/s10597-005-2599-z
30.
MerikangasK. R.HeJ. P.BursteinM.SwendsenJ.AvenevoliS.CaseB.OlfsonM. (2011). Service utilization for lifetime mental disorders in U.S. adolescents: Results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 50, 32–45. doi:10.1016/j.jaac.2010.10.006
31.
MeyersK.McLellanA. T.JaegerJ. L.PettinatiH. M. (1995). The development of the Comprehensive Addiction Severity Index for Adolescents (CASI-A): An interview for assessing multiple problems of adolescents. Journal of Substance Abuse Treatment, 12, 181–193. doi:10.1016/0740-5472(95)00009-T
32.
MolinaB. S.HinshawS. P.SwansonJ. M.ArnoldL. E.VitielloB.JensenP. S.HouckP. R. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child & Adolescent Psychiatry, 48, 484–500. doi:10.1097/CHI.0b013e31819c23d0
33.
MurphyK. (2005). Psychosocial treatments for ADHD in teens and adults: A practice-friendly review. Journal of Clinical Psychology, 61, 607–619. doi:10.1002/jclp.20123
34.
ObiohaO.AdesmanA. (2014). Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents. Current Opinion in Pediatrics, 26, 119–129. doi:10.1097/MOP.0000000000000053
35.
PelhamW. E.GnagyE. N.SibleyM. H.KippH. L.SmithB. H.EvansS. E.BuksteinO. (2013). Attributions and perception of methylphenidate effects in adolescents with ADHD. Journal of Attention Disorders. Advance online publication. doi:10.1177/1087054713493320
36.
PelhamW. E.SmithB. H.EvansS. W.BuksteinO.GnagyE. M.GreinerA. R.SibleyM. H. (2013). The effectiveness of short- and long-acting stimulant medications for adolescents with ADHD in a naturalistic secondary school setting. Journal of Attention Disorders. Advance online publication. doi:10.1177/1087054712474688
37.
RobinA. L. (2014). Family therapy for adolescents with ADHD. Child and Adolescent Psychiatric Clinics of North America, 23, 747–756. doi:10.1016/j.chc.2014.06.001
38.
RounsavilleB. J.CarrollK. M.OnkenL. S. (2001). A stage model of behavioral therapies research: Getting started and moving on from stage I. Clinical Psychology: Science and Practice, 8, 133–142. doi:10.1093/clipsy.8.2.133
39.
SanchezR.CrismonM.BarnerJ.BettingerT.WilsonJ. (2005). Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy, 25, 909–917. doi:10.1592/phco.2005.25.7.909
40.
SheehanD. V.LecrubierY.SheehanK. H.AmorimP.JanavsJ.WeillerE.. . . DunbarG. C. (1998). The Mini International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
41.
ShroutP. E.FleissJ. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86, 420–428. doi:10.1037//0033-2909.86.2.420
42.
SibleyM. H.KuriyanA. B.EvansS. W.WaxmonskyJ. G.SmithB. H. (2014). Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature. Clinical Psychology Review, 34, 218–232. doi:10.1016/j.cpr.2014.02.001
43.
SibleyM. H.PelhamW. E.MolinaB. S. G.GnagyE. M.WaschbuschD. A.GarefinoA. C.. . . KarchK. M. (2012). Diagnosing ADHD in adolescence. Journal of Consulting and Clinical Psychology, 80, 139–150. doi:10.1037/a0026577
44.
SmithB. H.BarkleyR. A.ShapiroC. (2006). Combined child therapies. In BarkleyR. A. (Ed.), Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed., pp. 678–691). New York, NY: Guilford.
45.
SmithB. H.WaschbuschD. A.WilloughbyM. T.EvansS. (2000). The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD). Clinical Child and Family Psychology Review, 3, 243–267. doi:10.1023/A:1026477121224
46.
SmithM. E.FarahM. J. (2011). Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, 137, 717–741. doi:10.1037/a0023825
47.
SobellM. B.SobellL. C. (2007). Substance use, health, and mental health. Clinical Psychology: Science and Practice, 14, 1–5. doi:10.1111/j.1468-2850.2007.00056.x
48.
Substance Abuse and Mental Health Services Administration. (2007). The OAS Report—A day in the life of American adolescents: Substance use facts. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
49.
Substance Abuse and Mental Health Services Administration. (2009). The NSDUH Report—Adolescent mental health: Service settings and reasons for receiving care. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
50.
SwansonJ.NolanW.PelhamW. E. (1992). The SNAP-IV rating scale. Available from http://www.myADHD.com
51.
TurnerW. C.MuckR. D.MuckR. J.StephensR. L.SukumarB. (2004). Co-occurring disorders in the adolescent mental health and substance abuse treatment systems. Journal of Psychoactive Drugs, 36, 455–462. doi:10.1080/02791072.2004.10524428
52.
VietaE. (2005). Improving treatment adherence in bipolar disorder through psychoeducation. Journal of Clinical Psychiatry, 66(Suppl. 1), 24–29.
53.
VisserS. N.DanielsonM. L.BitskoR. H.HolbrookJ. R.KoganM. D.GhandourR. M.. . . BlumbergS. J. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry, 53, 34–46. doi:10.1016/j.jaac.2013.09.001
54.
WalkerJ. S.ColemanD.LeeJ.SquireP. N.FriesenB. J. (2008). Children’s stigmatization of childhood depression and ADHD: Magnitude and demographic variation in a national sample. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 912–920. doi:10.1097/CHI.0b013e318179961a
55.
WaschbuschD. A.CunninghamC. E.PelhamW. E.Jr.RimasH. L.GreinerA. R.GnagyE. M.. . . HoffmanM. T. (2011). A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD. Journal of Clinical Child & Adolescent Psychology, 40, 546–561. doi:10.1080/15374416.2011.581617
56.
YehM.AaronsG. A.HoJ.LeslieL. K.McCabeK.TsaiK.HoughR. (2014). Parental etiological explanations and longitudinal medication use for youths with attention deficit hyperactivity disorder. Administration and Policy in Mental Health and Mental Health Services Research, 41, 401–409. doi:10.1007/s10488-013-0477-5
